The latest closing stock price for Rapport Therapeutics as of February 21, 2025 is 12.68.
An investor who bought $1,000 worth of Rapport Therapeutics stock at the IPO in 2024 would have $-390 today, roughly 0 times their original investment - a -39.04% compound annual growth rate over 1 years.
The all-time high Rapport Therapeutics stock closing price was 29.23 on October 16, 2024.
The Rapport Therapeutics 52-week high stock price is 29.74, which is 134.5% above the current share price.
The Rapport Therapeutics 52-week low stock price is 12.09, which is 4.7% below the current share price.
The average Rapport Therapeutics stock price for the last 52 weeks is 20.69.
An investor who bought $1,000 worth of Rapport Therapeutics stock at the IPO in 2024 would have $-390 today, roughly 0 times their original investment - a -39.04% compound annual growth rate over 1 years.
The all-time high Rapport Therapeutics stock closing price was 29.23 on October 16, 2024.
The Rapport Therapeutics 52-week high stock price is 29.74, which is 134.5% above the current share price.
The Rapport Therapeutics 52-week low stock price is 12.09, which is 4.7% below the current share price.
The average Rapport Therapeutics stock price for the last 52 weeks is 20.69.